HHS OIG – Policy & Medicine

Announcing the Launch of the This Week in Policy and Medicine Podcast

CMS Proposes Changes to Reporting and Returning Medicare Parts A and B Overpayments

Policy and Medicine Compliance Update August 2023 Issue Features: CMS Open Payments Reporting for 2023, Impact of Life Science Compliance, HHS-OIG revision of compliance guidance, and US Final Regulation for Drug Price Negotiations

Policy and Medicine Compliance Update April 2023 Issue Features: DOJ’s updated Evaluation of Compliance Program guidance, and End of COVID-19 Health Emergency What Does that Mean for Compliance

Allergan Botox Settlement and Corporate Integrity Agreement

Ortho-McNeil Settlement and Corporate Integrity Agreement

Astra Zeneca Seroquel Settlement and Corporate Integrity Agreement

Letters from Grassley: CDC Send Us Your Advisors Names

HHS OIG Report on CDC COI Forms: A Case of Different Priorities

Pfizer: $2.3 Billion Settlement and Corporate Integrity Agreement